Annual report pursuant to Section 13 and 15(d)

Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details)

v3.23.2
Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Beginning balance $ 822,101 $ 843,067
Eminence impairment   (8,275)
Acquisitions 51,257  
Adjustments   (4,407)
Currency translation (621) (8,284)
Ending balance 872,737 822,101
Protein Sciences    
Beginning balance 376,493 392,717
Eminence impairment   (8,275)
Acquisitions 51,257  
Currency translation (723) (7,949)
Ending balance 427,027 376,493
Diagnostics and Genomics    
Beginning balance 445,608 450,350
Adjustments   (4,407)
Currency translation 102 (335)
Ending balance $ 445,710 $ 445,608